Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.
Methylprednisolone is a prescription glucocorticoid used to treat selected inflammatory, allergic, immune-mediated, and endocrine conditions. Current oral tablets include 4 mg, 8 mg, 16 mg, and 32 mg strengths. It is the active ingredient in Medrol and is also available in injectable formulations with different administration instructions.
read more about methylprednisolone ...Methylprednisolone binds to glucocorticoid receptors and changes the activity of genes involved in inflammation and immune responses. This reduces inflammatory cell activity, tissue swelling, and immune signaling. It also influences blood glucose regulation, protein metabolism, and normal adrenal hormone production.
Oral methylprednisolone is used for selected rheumatic diseases, severe allergic reactions, inflammatory skin and respiratory conditions, autoimmune disorders, blood diseases, and endocrine disorders such as adrenal insufficiency. Treatment depends on the underlying diagnosis and clinical severity. Systemic fungal infections and known hypersensitivity to the medicine are contraindications.
The initial oral dose commonly ranges from 4 mg to 48 mg daily, depending on the condition and severity. Higher doses can be prescribed for selected serious disorders. Dosing is adjusted according to response, then reduced to the lowest amount that controls the condition. Patients receiving prolonged treatment generally require gradual dose reduction rather than abrupt discontinuation.
Methylprednisolone suppresses immune activity and can increase susceptibility to serious infections or reactivate latent infections. Other risks include adrenal suppression, elevated blood glucose, high blood pressure, fluid retention, osteoporosis, gastrointestinal bleeding or ulcers, psychiatric reactions, glaucoma, and cataracts. Sudden discontinuation after prolonged use can cause adrenal insufficiency.
It treats selected inflammatory, allergic, autoimmune, respiratory, blood, and endocrine disorders.
Current tablet labeling describes initial doses of 4 mg to 48 mg daily, with individual adjustment according to the condition.
Yes. Medrol is a trade name for methylprednisolone tablets.
Prolonged treatment generally requires gradual dose reduction to avoid adrenal insufficiency and withdrawal symptoms.
DailyMed - METHYLPREDNISOLONE tablet. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=237c32a4-e029-2541-e063-6394a90af122. Date Accessed October 14, 2026.
Methylprednisolone. Drugs and Lactation Database (LactMed). https://www.ncbi.nlm.nih.gov/books/NBK501028/. Date Accessed October 14, 2026.
Methylprednisolone. MedlinePlus. https://medlineplus.gov/druginfo/meds/a682795.html. Date Accessed October 14, 2026.
Methylprednisolone. PubChem. https://pubchem.ncbi.nlm.nih.gov/compound/Methylprednisolone. Date Accessed October 14, 2026.
Methylprednisolone. StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK544340/. Date Accessed October 14, 2026.